Psychological impact of the COVID-19 pandemic on patients with allergic diseases
On March 2020, WHO declared COVID-19 as a pandemic disease. Interactions between allergy-related inflammatory and psychiatric disorders including depression, anxiety and posttraumatic stress disorder (PTSD) have been documented. Therefore, those who have pre-existing allergic conditions may have an...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Lippincott Williams & Wilkins
2021
|
| Subjects: | |
| Online Access: | http://eprints.uanl.mx/20763/1/20763.pdf |
| _version_ | 1824415945720856576 |
|---|---|
| author | González Díaz, Sandra Nora Martin, Bryan Villarreal González, Rosalaura Virginia De Lira Quezada, Cindy Elizabeth Macouzet Sánchez, Carlos Macías Weinmann, Alejandra Guzmán Avilán, Rosa Ivett García Campa, Mariano Noyola Pérez, Andrés García González, David Uriel |
| author_facet | González Díaz, Sandra Nora Martin, Bryan Villarreal González, Rosalaura Virginia De Lira Quezada, Cindy Elizabeth Macouzet Sánchez, Carlos Macías Weinmann, Alejandra Guzmán Avilán, Rosa Ivett García Campa, Mariano Noyola Pérez, Andrés García González, David Uriel |
| author_sort | González Díaz, Sandra Nora |
| collection | Repositorio Institucional |
| description | On March 2020, WHO declared COVID-19 as a pandemic disease. Interactions between allergy-related inflammatory and psychiatric disorders including depression, anxiety and posttraumatic stress disorder (PTSD) have been documented. Therefore, those who have pre-existing allergic conditions may have an increased psychiatric reaction to the stresses of the COVID-19 pandemic.
Objective
Identify the psychological impact of COVID-19 in patients with allergic diseases and determine if these individuals have a greater risk of presenting with post-traumatic stress disorder (PTSD).
Methods
It is a cross-sectional, survey-based study designed to assess the degree of symptoms of depression and the risk of PTSD using the Patient Health Questionnaire (PHQ-9) and the Impact of Event Scale–Revised (IES-R), respectively in allergic patients.
Results
A total of 4,106 surveys were evaluated; 1,656 (40.3%) were patients with allergic disease, and 2,450 (59.7%) were non-allergic (control) individuals. Of those with allergies, 76.6% had respiratory allergic disease including asthma and allergic rhinitis. Individuals with allergic disease reported higher scores regarding symptoms of PTSD on the IES-R scale (p = 0.052, OR 1.24 CI .99 - 1.55) as well as a higher depression risk score in the PHQ-9 questionnaire (mean 6.82 vs. 5.28) p = 0.000 z = -8.76.
The allergy group presented a higher score in the IES-R questionnaire (mean 25.42 vs. 20.59), being more susceptible to presenting PTSD (p = 0.000, z = -7.774).
The individuals with allergic conditions were further divided into subgroups of those with respiratory allergies such as allergic rhinitis and asthma vs those with non-respiratory allergies such as drug and food allergy, urticaria and atopic dermatitis. This subgroup analysis compares respiratory versus non-respiratory allergic patients, with similar results on the IES-R (mean 25.87 vs 23.9) p = 0.0124, z = -1.539. There was no significant difference on intrusion (p=0.061, z=-1.873) and avoidance (p=0.767, z=-0.297), but in the hyperarousal subscale, patients with respiratory allergy had higher scores (mean 1.15 vs. 0.99) p = 0.013 z = -2.486.
Conclusions
Psychological consequences such as depression and reported PTSD are present during the COVID-19 pandemic causing an impact particularly in individuals with allergic diseases. If we acknowledge the impact and how it is affecting our patients, we are able to implement interventions, follow up and contribute to the overall well-being. |
| format | Article |
| id | eprints-20763 |
| institution | UANL |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | eprints |
| spelling | eprints-207632021-05-04T13:02:43Z http://eprints.uanl.mx/20763/ Psychological impact of the COVID-19 pandemic on patients with allergic diseases González Díaz, Sandra Nora Martin, Bryan Villarreal González, Rosalaura Virginia De Lira Quezada, Cindy Elizabeth Macouzet Sánchez, Carlos Macías Weinmann, Alejandra Guzmán Avilán, Rosa Ivett García Campa, Mariano Noyola Pérez, Andrés García González, David Uriel BF Psicología RC Medicina Interna, Psiquiatría, Neurología On March 2020, WHO declared COVID-19 as a pandemic disease. Interactions between allergy-related inflammatory and psychiatric disorders including depression, anxiety and posttraumatic stress disorder (PTSD) have been documented. Therefore, those who have pre-existing allergic conditions may have an increased psychiatric reaction to the stresses of the COVID-19 pandemic. Objective Identify the psychological impact of COVID-19 in patients with allergic diseases and determine if these individuals have a greater risk of presenting with post-traumatic stress disorder (PTSD). Methods It is a cross-sectional, survey-based study designed to assess the degree of symptoms of depression and the risk of PTSD using the Patient Health Questionnaire (PHQ-9) and the Impact of Event Scale–Revised (IES-R), respectively in allergic patients. Results A total of 4,106 surveys were evaluated; 1,656 (40.3%) were patients with allergic disease, and 2,450 (59.7%) were non-allergic (control) individuals. Of those with allergies, 76.6% had respiratory allergic disease including asthma and allergic rhinitis. Individuals with allergic disease reported higher scores regarding symptoms of PTSD on the IES-R scale (p = 0.052, OR 1.24 CI .99 - 1.55) as well as a higher depression risk score in the PHQ-9 questionnaire (mean 6.82 vs. 5.28) p = 0.000 z = -8.76. The allergy group presented a higher score in the IES-R questionnaire (mean 25.42 vs. 20.59), being more susceptible to presenting PTSD (p = 0.000, z = -7.774). The individuals with allergic conditions were further divided into subgroups of those with respiratory allergies such as allergic rhinitis and asthma vs those with non-respiratory allergies such as drug and food allergy, urticaria and atopic dermatitis. This subgroup analysis compares respiratory versus non-respiratory allergic patients, with similar results on the IES-R (mean 25.87 vs 23.9) p = 0.0124, z = -1.539. There was no significant difference on intrusion (p=0.061, z=-1.873) and avoidance (p=0.767, z=-0.297), but in the hyperarousal subscale, patients with respiratory allergy had higher scores (mean 1.15 vs. 0.99) p = 0.013 z = -2.486. Conclusions Psychological consequences such as depression and reported PTSD are present during the COVID-19 pandemic causing an impact particularly in individuals with allergic diseases. If we acknowledge the impact and how it is affecting our patients, we are able to implement interventions, follow up and contribute to the overall well-being. Lippincott Williams & Wilkins 2021-01-07 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/20763/1/20763.pdf http://eprints.uanl.mx/20763/1.haspreviewThumbnailVersion/20763.pdf González Díaz, Sandra Nora y Martin, Bryan y Villarreal González, Rosalaura Virginia y De Lira Quezada, Cindy Elizabeth y Macouzet Sánchez, Carlos y Macías Weinmann, Alejandra y Guzmán Avilán, Rosa Ivett y García Campa, Mariano y Noyola Pérez, Andrés y García González, David Uriel (2021) Psychological impact of the COVID-19 pandemic on patients with allergic diseases. World Allergy Organization Journal, 14 (3). pp. 1-10. ISSN 1939-4551 doi:org/10.1016/j.waojou.2021.100510 |
| spellingShingle | BF Psicología RC Medicina Interna, Psiquiatría, Neurología González Díaz, Sandra Nora Martin, Bryan Villarreal González, Rosalaura Virginia De Lira Quezada, Cindy Elizabeth Macouzet Sánchez, Carlos Macías Weinmann, Alejandra Guzmán Avilán, Rosa Ivett García Campa, Mariano Noyola Pérez, Andrés García González, David Uriel Psychological impact of the COVID-19 pandemic on patients with allergic diseases |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | Psychological impact of the COVID-19 pandemic on patients with allergic diseases |
| title_full | Psychological impact of the COVID-19 pandemic on patients with allergic diseases |
| title_fullStr | Psychological impact of the COVID-19 pandemic on patients with allergic diseases |
| title_full_unstemmed | Psychological impact of the COVID-19 pandemic on patients with allergic diseases |
| title_short | Psychological impact of the COVID-19 pandemic on patients with allergic diseases |
| title_sort | psychological impact of the covid 19 pandemic on patients with allergic diseases |
| topic | BF Psicología RC Medicina Interna, Psiquiatría, Neurología |
| url | http://eprints.uanl.mx/20763/1/20763.pdf |
| work_keys_str_mv | AT gonzalezdiazsandranora psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT martinbryan psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT villarrealgonzalezrosalauravirginia psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT deliraquezadacindyelizabeth psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT macouzetsanchezcarlos psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT maciasweinmannalejandra psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT guzmanavilanrosaivett psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT garciacampamariano psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT noyolaperezandres psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases AT garciagonzalezdaviduriel psychologicalimpactofthecovid19pandemiconpatientswithallergicdiseases |